CD274 and cancer: Therefore, it is essential to note that the aim of this research was not to compare the preclinical data of [18F]AlF-NOTA-iPD-L1 with those of various radiotracers targeting PD-L1, but rather to show that [18F]AlF-NOTA-iPD-L1 can be helpful as a theranostic pair with [177Lu]Lu-DOTA-iPD-L1; paving the way for advancements in cancer diagnosis and theranostics with focus on the immunomodulatory effect of the 177Lu radiopharmaceutical pair [12], moving beyond its simple tumor radiation absorbed dose.